Fintech Banking for business that offer CBD | SpinGraph: Regulatory blame shift
SpinGraph analysis of Reddit r/fintech's Fintech Banking for business that offer CBD story: regulatory blame shift, The Shield, Spin Score 35%, low AI repetiti…
Know the moment AI knows your story. Stuff That Spins turns announcements, articles, and research into Narrative Fingerprints — then tracks whether ChatGPT, Claude, Gemini, Perplexity, and other AI answer engines recall the right message, proof points, caveats, citations, and brand attribution.
Fintech Banking for business that offer CBD
CBD banking, fintech exclusion, hemp compliance
User operates a large nutraceutical business with ~10% CBD-containing OTC products Traditional and major fintech banks (e.g., Rho, Brex) have declined banking services No viable fintech banking alternatives identified in the post
Emphasizes regulatory ambiguity as the cause of exclusion while minimizing fintechs’ discretionary compliance thresholds, commercial risk modeling, or inconsistent enforcement across peers.
Fintechs as cautious, rule-following intermediaries navigating unclear legal terrain.
Fintech banks reject CBD-related businesses due to regulatory uncertainty.
Federal banking regulators’ actual stance on hemp-derived CBD (e.g., FinCEN guidance, FDIC statements); Whether the user’s products comply with 2018 Farm Bill definitions and third-party lab verification status; Public disclosures from cited fintechs about their CBD-related underwriting criteria
The story moves blame, risk, or obligation away from the main actor toward external forces, partners, regulators, or abstract systems. Watch for loaded terms such as old School, convoluted, modern banks. The distribution reads as forum support request. A pressure point: Federal banking regulators’ actual stance on hemp-derived CBD (e.g., FinCEN guidance, FDIC statements).
Most fintech banks like RHO and Brex have said no to banking our nutraceutical business because it includes CBD products.
Despite those products being roughly 10% of our total sales most of those options have said no.
Extracted statistics from the source narrative
User estimates CBD products constitute roughly 10% of total sales